Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centogene AG - |
RCV001251154 | SCV001426553 | likely pathogenic | Cerebral cavernous malformation 2 | criteria provided, single submitter | clinical testing | ||
3billion | RCV001251154 | SCV002058922 | pathogenic | Cerebral cavernous malformation 2 | 2022-01-03 | criteria provided, single submitter | clinical testing | The variant has been reported to be associated with CCM2 related disorder (ClinVar ID: VCV000974868, 3billion dataset). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000012, PM2_M). Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_VS).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |